Ebb & Flow

While hot life science technologies come and go, VCs are reminding themselves that patience, combined with fundamental investment strategies like targeting big markets, sound management and a solid business plan never go out of style. That was the takeaway message from a venture capital panel at the Lehman Brothers' Healthcare 2001 conference in Orlando, Fla., last week. The panel also offered up opinions on where the hot spaces are, and how they are coaching their portfolio companies to deal with the turbulent public market.

The group - Farah Champsi of Alta Partners; Jonathan Leff of Warburg Pincus; Thomas Liston of Humana Ventures; Barbara Lubash of Versant Ventures; and Michael Meyers of Global Bio Medical Partners - all had a bent towards product companies. ...